119 related articles for article (PubMed ID: 37800769)
1. Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis.
Liu L; Chen B
Medicine (Baltimore); 2023 Oct; 102(40):e35286. PubMed ID: 37800769
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
4. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
[TBL] [Abstract][Full Text] [Related]
5. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
6. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
8. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
9. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
10. Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.
Jin L; Su X; Li W; Wu J; Zhang H
Sci Rep; 2024 Mar; 14(1):5766. PubMed ID: 38459103
[TBL] [Abstract][Full Text] [Related]
11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Slaby O; Demlova R; Svoboda M; Kiss I
Front Oncol; 2020; 10():573394. PubMed ID: 33585194
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.
Lee YT; Liu CJ; Hu YW; Teng CJ; Tzeng CH; Yeh CM; Chen TJ; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC; Chen MH; Teng HW; Liu JH; Yen CC
Medicine (Baltimore); 2015 Jul; 94(26):e1079. PubMed ID: 26131831
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors, treatment decisions, and nomograms for patients with second primary lung cancer following colorectal cancer: a population-based study.
Shang J; Kulabieke D; Zhu J; Guo B; Zheng X; Qian J
Updates Surg; 2023 Oct; 75(7):1827-1842. PubMed ID: 37535188
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
16. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
17. Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer.
Wu M; Huang M; He C; Chen C; Li H; Wang J; Liu M; Fu G; Lei Z; Chu X
Front Oncol; 2021; 11():650937. PubMed ID: 33777813
[No Abstract] [Full Text] [Related]
18. The risk of developing second primary malignancies among colorectal cancer patients.
Du S; Li Y; Sun H; Deng G; Tang S; Zeng F; Zhang B; Cui B
Aging (Albany NY); 2022 Aug; 14(16):6756-6779. PubMed ID: 36036758
[TBL] [Abstract][Full Text] [Related]
19. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
20. Temporal trend in relative risk of second primary colorectal cancer.
Das A; Chak A; Cooper GS
Am J Gastroenterol; 2006 Jun; 101(6):1342-7. PubMed ID: 16771959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]